0ROG Stock Overview
Galenica AG operates as a healthcare service provider in Switzerland and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Galenica AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF70.65 |
| 52 Week High | CHF81.00 |
| 52 Week Low | CHF65.20 |
| Beta | 0.18 |
| 1 Month Change | -5.05% |
| 3 Month Change | -5.80% |
| 1 Year Change | -12.14% |
| 3 Year Change | 13.61% |
| 5 Year Change | 36.16% |
| Change since IPO | 64.38% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0ROG | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 1.7% | 1.4% | 2.7% |
| 1Y | -12.1% | -29.1% | 0.3% |
Return vs Industry: 0ROG exceeded the UK Healthcare industry which returned -29.1% over the past year.
Return vs Market: 0ROG underperformed the UK Market which returned 0.3% over the past year.
Price Volatility
| 0ROG volatility | |
|---|---|
| 0ROG Average Weekly Movement | 2.1% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0ROG has not had significant price volatility in the past 3 months.
Volatility Over Time: 0ROG's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1927 | 6,181 | Marc Werner | www.galenica.com |
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands.
Galenica AG Fundamentals Summary
| 0ROG fundamental statistics | |
|---|---|
| Market cap | CHF3.52b |
| Earnings (TTM) | CHF164.92m |
| Revenue (TTM) | CHF3.76b |
21.3x
P/E Ratio0.9x
P/S RatioIs 0ROG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0ROG income statement (TTM) | |
|---|---|
| Revenue | CHF3.76b |
| Cost of Revenue | CHF3.29b |
| Gross Profit | CHF461.34m |
| Other Expenses | CHF296.43m |
| Earnings | CHF164.92m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 06, 2024
| Earnings per share (EPS) | 3.31 |
| Gross Margin | 12.28% |
| Net Profit Margin | 4.39% |
| Debt/Equity Ratio | 33.2% |
How did 0ROG perform over the long term?
See historical performance and comparison